What are the treatment options for hair loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hair Loss Treatment Options

For androgenetic alopecia (pattern hair loss), start with topical minoxidil 5% applied twice daily, which is the FDA-approved first-line treatment with proven efficacy in both men and women. 1, 2

First-Line Treatment: Topical Minoxidil

For Men

  • Apply minoxidil 5% topical solution 1 mL twice daily directly to the scalp 1
  • Treatment works best for vertex (crown) hair loss, not frontal baldness or receding hairline 1
  • Results typically appear at 2 months, but may require 4 months of consistent use before visible improvement 1
  • Initial temporary increase in hair shedding for up to 2 weeks is expected and indicates the medication is working 1
  • Treatment must be continued indefinitely—discontinuation reverses all benefits 2

For Women

  • Use minoxidil 5% foam once daily OR minoxidil 2% solution twice daily 3, 4
  • The 5% concentration demonstrates superior efficacy compared to 2% in controlled trials, with greater improvement in hair count and patient satisfaction 4
  • Women should avoid the 5% solution formulation marketed for men, as the 5% foam is specifically FDA-approved for female pattern hair loss 3
  • Both concentrations improve psychosocial perceptions and quality of life even when hair regrowth is modest 4

Important Caveats with Minoxidil

  • Efficacy ranges from 17-70% depending on concentration and individual response 5
  • Common side effects include scalp pruritus, local irritation, and unwanted facial hair growth (hypertrichosis), particularly with 5% concentration 4
  • Does NOT work for hair loss caused by medications, nutritional deficiencies, thyroid disease, scarring alopecia, or tight hairstyles 1

Advanced Treatment: Platelet-Rich Plasma (PRP)

For patients seeking enhanced results or those with inadequate response to minoxidil alone, add PRP injections using a specific protocol. 2

PRP Treatment Protocol

  • Preparation method: Manual double-spin technique targeting 1-1.5 million platelets/µL; activation is NOT required 2
  • Initial phase: 3-5 treatment sessions spaced 1 month apart 2
  • Dosing: 5-7 mL total PRP volume, injecting 0.05-0.1 mL/cm² at 1 cm intervals 2
  • Injection technique: 90-degree angle, 2-4 mm depth, using 30G × 4mm needles 2
  • Maintenance phase: Single session every 6 months after initial treatment series 2
  • Pain management: Apply pharmaceutical-grade topical anesthetic cream before injection—this is strongly recommended as the procedure causes significant discomfort 2

Combination Therapy Superiority

  • PRP combined with topical minoxidil 5% demonstrates superior efficacy compared to either treatment alone, with the highest increase in hair density in comparative studies 2, 6
  • This combination is significantly more effective than minoxidil monotherapy 2
  • PRP monotherapy shows greater effectiveness than minoxidil monotherapy in most studies 6

PRP Evidence Considerations

  • Higher platelet concentrations produce greater effects on hair density, follicle diameter, and terminal hair density 6
  • Microneedling application may be superior to injection technique for some parameters 6
  • Some studies report ineffectiveness, possibly due to low platelet concentration, inadequate volume, insufficient treatment frequency, or individual genetic factors 6

Additional Treatment Options

Low-Level Laser Therapy (LLLT)

  • 655-nm laser devices used 3 times per week demonstrate efficacy for androgenetic alopecia 6, 2
  • Requires continuous use similar to minoxidil 6

Oral Minoxidil (Off-Label)

  • Low-dose oral minoxidil 1 mg daily shows comparable efficacy to topical 5% solution in recent trials 7
  • May be considered for patients with poor adherence to topical application or scalp irritation 7
  • Both formulations show >60% patient satisfaction with no significant difference in outcomes 7

Other Modalities

  • Hormonal therapies, nutraceuticals, exosome treatments, and hair transplantation are available but beyond first-line recommendations 6

Treatment Monitoring

Evaluate treatment response using multiple objective measures at regular intervals. 2

Assessment Methods

  • Standardized before-and-after photographs for visual comparison 6, 2
  • Trichoscopy to examine hair follicles, identify miniaturization, and assess vellus hair presence 6
  • Hair counts in specific scalp areas before and after treatment 6
  • Hair diameter measurements using micrometer—increased shaft diameter indicates positive response 6
  • Patient self-assessment questionnaires for satisfaction and perceived improvement 6, 2
  • Pull test to assess hair fragility—fewer hairs removed indicates improved strength 6

Timeline for Evaluation

  • Initial assessment at 2-4 months for minoxidil 1
  • Comprehensive evaluation after one year for PRP combination therapy 2
  • Treatment efficacy may decrease with greater severity and longer duration of alopecia 2

Alopecia Areata: Different Treatment Approach

For patchy autoimmune hair loss (alopecia areata), the treatment algorithm differs completely from androgenetic alopecia. 8

Limited Patchy Alopecia Areata

  • First-line: Intralesional corticosteroids (triamcinolone acetonide 5-10 mg/mL) injected monthly 8, 6
  • Success rates up to 62% with monthly injections 8
  • Most suitable for fewer than 5 patches <3 cm diameter and cosmetically sensitive areas like eyebrows 6
  • Monitor for skin atrophy, a consistent side effect 8

Extensive Patchy Alopecia Areata

  • First-line: Contact immunotherapy with diphenylcyclopropenone (DPCP) 8
  • Stimulates cosmetically worthwhile regrowth in <50% of patients 8
  • Requires specialized protocols with sensitization followed by weekly applications at increasing concentrations 6

Important Distinction

  • Minoxidil is NOT first-line therapy for alopecia areata, showing limited efficacy with variable response rates of only 32-33% 8, 6
  • For limited disease <1 year duration, observation without treatment is legitimate as spontaneous remission occurs in up to 80% of cases 8

References

Guideline

Treatment Options for Female Androgenetic Alopecia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Alopecia Areata

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.